Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(13)
DRUG(1)
DEVICE(1)
Laboratory Biomarker Analysis
3 trials
not_applicable
university-of-southern-california
Cytology Specimen Collection Procedure
2 trials
university-of-southern-california
pharmacological study
1 trial
phase_1
california-cancer-consortium
Magnetic Resonance Imaging
1 trial
university-of-southern-california
Survey Administration
1 trial
university-of-southern-california
CNTO 328
1 trial
phase_2
swog-cancer-research-network
Interview
1 trial
university-of-southern-california
fenretinide
1 trial
phase_1
california-cancer-consortium

+4 more interventions

12 unique interventions3 categories

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Completed2
Terminated1
Other3

Role Distribution

Principal Investigator4
Other Roles2
PI Rate67%

Activity Timeline

Clinical Trials (6)

NCT03568292Not ApplicableSuspended
Virtual Reality in Reducing Pain and Anxiety in Cancer Participants Undergoing Painful Procedures
Malignant Neoplasm
PrincipalinvestigatorStart date: 2022-03-01
NCT03563352Withdrawn
Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer
Breast CarcinomaCholangiocarcinomaColorectal Carcinoma+4 more
PrincipalinvestigatorStart date: 2018-08-30
NCT02853097Terminated
Cell-Free DNA and RNA in Blood fromMetastatic Prostate Cancer Patients
Hormone-Resistant Prostate CancerMetastatic Prostate CarcinomaProstate Adenocarcinoma
PrincipalinvestigatorStart date: 2016-06-14
NCT02664883Active Not Recruiting
Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer
Healthy SubjectMetastatic Renal Cell CancerRecurrent Renal Cell Carcinoma+3 more
PrincipalinvestigatorStart date: 2015-09-08
NCT00387504Phase 1Completed
Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors
Unspecified Adult Solid Tumor, Protocol Specific
Studychair
NCT00433446Phase 2Completed
S0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
Prostate Cancer
Studychair

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Prostate CancerProstate AdenocarcinomaMetastatic Prostate Carcinoma+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Aminah Jatoi, MD

Mayo Clinic

Related
29 trials

Shared therapeutic areas:

Unspecified Adult Solid Tumor, Protocol SpecificProstate CancerCancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Eric Bellissant, MD, PhD

Rennes University Hospital

Related
26 trials

Shared therapeutic areas:

Colorectal CancerProstate AdenocarcinomaProstate Cancer
Similarity Score5%

Jeong Min Lee, MD

Seoul National University Hospital

Related
34 trials

Shared therapeutic areas:

CholangiocarcinomaColorectal Cancer
Similarity Score3%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

CancerColorectal Cancer
Similarity Score3%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

CancerUnspecified Adult Solid Tumor, Protocol Specific

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Colorectal CancerMetastatic Renal Cell Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Saleh K Saleh, MD

Minia University

Related
23 trials

Shared therapeutic areas:

CholangiocarcinomaColorectal Cancer
Similarity Score3%

BERNARD BELAIGUES

Assistance Publique hôpitaux de Marseille

Related
26 trials

Shared therapeutic areas:

Breast CarcinomaCancer
Similarity Score3%

Mark Levine, MD

Ontario Clinical Oncology Group (OCOG)

Related
13 trials

Shared therapeutic areas:

Prostate CancerColorectal Cancer
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT03568292Not ApplicablePrincipalInvestigator

Virtual Reality in Reducing Pain and Anxiety in Cancer Participants Undergoing Painful Procedures

Malignant Neoplasm
Suspended
NCT03563352PrincipalInvestigator

Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer

Breast CarcinomaCholangiocarcinomaColorectal Carcinoma+4 more
Withdrawn
NCT02853097PrincipalInvestigator

Cell-Free DNA and RNA in Blood fromMetastatic Prostate Cancer Patients

Hormone-Resistant Prostate CancerMetastatic Prostate CarcinomaProstate Adenocarcinoma
Terminated
NCT02664883PrincipalInvestigator

Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer

Healthy SubjectMetastatic Renal Cell CancerRecurrent Renal Cell Carcinoma+3 more
Active Not Recruiting
NCT00387504Phase 1StudyChair

Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific
Completed
NCT00433446Phase 2StudyChair

S0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Prostate Cancer
Completed

All 6 trials loaded